The ibs.GRANADA promotes a historic meeting between researchers and patient associations in Granada
The conference, which was held in the assembly hall of the Virgen de las Nieves University Hospital, constitutes a key event in the strategic union between researchers and associations to advance health care in the region
This Monday, the Biosanitary Research Institute of Granada (ibs.GRANADA) held an unprecedented meeting between researchers and patient associations in Granada. Under the motto “Advancing Together”, this event marks a milestone in collaboration between key entities in the field of health.
The Conference began with a warm institutional welcome in which we included the managing director of the Virgen de las Nieves University Hospital, María Ángeles García Rescalvo; the Medical Director of the San Cecilio Clinical University Hospital, Susana Moya Roldán; the delegate of the rector for Health and Relations with the Health System of the University of Granada, José Juan Jiménez Moleón, the scientific director of ibs.GRANADA, María José Sánchez Pérez and Antonio Hermoso Quintana, spokesperson for the Platform of Patient Associations of Granada and president of the associations of ostomates (AOGRA) and of Crohn's and ulcerative colitis patients (ACCU) of Granada.
After the institutional welcome, María José Sánchez Pérez, scientific director of ibs.GRANADA, made a speech entitled “What is it and what do we research at ibs.GRANADA? Collaboration is necessary” in which she has explored the importance of collaboration in research and the actions that she is carrying out from the Institute in this regard. Next, Antonio Hermoso, president of ACCU, AOGRA and spokesperson for the Platform of Patient Associations of Granada, addressed the needs and expectations of the Patient Associations of Granada, in the field of research, as well as implementing avenues of collaboration between the associations of patients with ibs.GRANADA.
The event continued with a moderated debate on the joint progress of researchers and patient associations, led by Encarnación González Flores, Joan Carles March and Enrique Raya, prominent professionals and leaders in their respective fields of research. Finally, the conclusions of the event were presented by María José Sánchez, scientific director of ibs.GRANADA and Caridad Peregrin González, president of the Granada Association of Multiple Sclerosis, where they summarized the key points addressed during the day.
This event represents a unique opportunity to foster collaboration between researchers and patient associations, promoting constructive dialogue and sharing perspectives to drive significant advances in the field of health in Granada.
About the ibs.GRANADA
The Instituto de Investigación Biosanitaria ibs.GRANADA, is the only center accredited by the Carlos III Health Institute (ISCIII) that develops biomedical research of excellence in Granada and one of the four accredited in Andalusia by the ISCIII.
The ibs.GRANADA is structured into four Scientific Areas: Oncology, Precision Medicine, Epidemiology and Public Health and Technology and Advanced Therapies that develop intense research activity and lead the transfer of research results to society, which are reflected in the 1.063 publications made in scientific journals, which add up to a total of 6.528 impact factor points in 2022.
Currently, the Institute brings together more than 1.100 professionals and 70 multidisciplinary research groups that make up, from the University of Granada, the Virgen de las Nieves University Hospital, the San Cecilio Clinical University Hospital, the Andalusian School of Public Health and Primary Care Centers in Granada.
The primary objectives of ibs.GRANADA are to promote biomedical, clinical and epidemiological research carried out by the different groups attached to the institute and to facilitate translational research in Granada hospitals. This research activity translates into the generation of knowledge and the transfer of scientific advances towards the prevention, diagnosis and treatment of priority health problems.